Queensland Life Sciences Industry Report 2012 (PDF, 3.5MB)

Since VenturePro was established in 2005, about 75% of our
clients who engaged us to play a major role in their submissions
were successful, with over $400 million being awarded to over
60 projects.
The primary authors of this report were Dr Patrick Silvey and
Dr Lavinia Proctor. We would like to acknowledge the expert
contribution of Dr Lahn Straney in developing and applying the
statistical methodology that enabled us to put forward estimates
of key measures at a state-wide level. The principal contact at
VenturePro is Dr Patrick Silvey — patrick.silvey@venturepro.com.
au; Ph: +61 (7) 3010 5728; 0402 308 922.
Dr Patrick Silvey (MBA, PhD, BSc (Hons))
Managing Director, VenturePro Pty. Ltd
Patrick has many years’ experience in delivering
professional services and in the management
of major consultancies with public and private
sector clients, and he has worked in the venture
finance industries in Queensland and California. He was previously
a Director in Corporate Finance at PricewaterhouseCoopers
(PwC) and a post-doctoral research fellow at The University
of Queensland. He was a member of the QUT Research and
Innovation Committee and the i.lab technology incubator Advisory
Panel for nine years. While at PwC, Patrick was the key member of
a division that focused on Companies with Extraordinary Potential
and he was appointed to the PwC Global Thought Leadership
Team in Life Sciences in 2004. Patrick’s MBA degree focussed on
entrepreneurship and new venture finance and he was awarded a
university medal from QUT in 2001 as the MBA graduate with the
highest overall GPA.
Dr Lavinia Proctor
(PhD, Grad Cert Applied Law, BSc (Hons I))
Associate Director, VenturePro Pty. Ltd.
Dr Lavinia Proctor has served as an Associate
Director at VenturePro for the past three
years. During this time she has contributed to
the development of large collaborative funding bids, business
cases for infrastructure and other funding, business plans and
reports for government and research sector clients. Previously,
Lavinia held executive and senior management roles in two
unlisted Australian biotechnology companies. In these roles,
Lavinia was responsible for intellectual property management,
in-licensing activities, pre-clinical product development
campaigns and co-ordinating relationships with contract research
organisations, granting bodies and regulatory authorities. She
also was responsible for securing and managing several state
and federal government grants. She holds a PhD from The
University of Queensland, has co-authored fourteen peer-reviewed
international publications and is currently undertaking a law
degree (LLB).
Dr Lahn Straney (PhD, BBiotech(Hons))
Postdoctoral Fellow, Monash University
and VenturePro Consultant
Lahn has worked in an analytical role in various
fields including environmental sciences,
biotechnology, economics and health. He
has provided technical and writing support for several grant
applications in varied programs and scientific disciplines. Lahn
has gained professional experience in market research, analytical
research and statistical analysis through his previous roles and
consultancies with Progen Pharmaceuticals, the Australian
Institute for Commercialisation and VenturePro Pty Ltd. He
has also developed and executed a number of primary surveys
to industry and stakeholders on behalf of private and
government clients.
Suggested Citation
Silvey, P. and Proctor, L. (2012). The Queensland Life Sciences
Industry Report 2012. Brisbane: Queensland Department of
Science, Information Technology, Innovation and the Arts.
This work is copyright.
Apart from any use as permitted under the Copyright Act 1968 (Cth),
no part may be reproduced by any process without prior written
permission from the Queensland Government. Enquiries concerning
reproduction and rights should be addressed to the Queensland
Department of Science, Information Technology, Innovation and
the Arts.
03